A Forbes.com post reports that throughout the marketing of the 2012 Super Bowl, a post on the Eli Lilly blog site discloses the company invests approximately $1.3 billion to bring a brand-new drug on the marketplace. Forbes and Bernard Munos of the InnoThink Center for Research study in
Read more...
No comments:
Post a Comment